These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8284259)

  • 1. Influence of chronic intracerebroventricular infusion of vasoactive intestinal peptide (VIP) on memory processes in Morris water pool test in the rat.
    Takashima A; Maeda Y; Itoh S
    Peptides; 1993; 14(5):1073-8. PubMed ID: 8284259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired spatial learning by vasoactive intestinal peptide in Morris water maze task in the rat.
    Itoh S; Takashima A; Morimoto T
    Can J Physiol Pharmacol; 1994 Jan; 72(1):25-9. PubMed ID: 8012894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide (VIP) causes memory impairment in passive avoidance responding of the rat.
    Takashima A; Maeda Y; Itoh S
    Peptides; 1993; 14(5):1067-71. PubMed ID: 8284258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of infusion of vasoactive intestinal peptide (VIP)-antisense oligodeoxynucleotide into the third cerebral ventricle above the hypothalamic suprachiasmatic nucleus on the hyperglycemia caused by intracranial injection of 2-deoxy-D-glucose in rats.
    Chun S; Niijima A; Shima T; Okada M; Nagai K
    Neurosci Lett; 1998 Dec; 257(3):135-8. PubMed ID: 9870338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal asymmetry in exploratory behavior to vasoactive intestinal polypeptide.
    Ivanova M; Ternianov A; Belcheva S; Tashev R; Negrev N; Belcheva I
    Peptides; 2008 Jun; 29(6):940-7. PubMed ID: 18321609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateralized hippocampal effects of vasoactive intestinal peptide on learning and memory in rats in a model of depression.
    Ivanova M; Belcheva S; Belcheva I; Negrev N; Tashev R
    Psychopharmacology (Berl); 2012 Jun; 221(4):561-74. PubMed ID: 22160165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics and toxicity of vasoactive intestinal peptide for intranasal administration.
    Cui X; Cao DY; Wang ZM; Zheng AP
    Pharmazie; 2013 Jan; 68(1):69-74. PubMed ID: 23444784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of vasoactive intestinal peptide in the control of prolactin-induced turkey incubation behavior. II. Chronic infusion of vasoactive intestinal peptide.
    Pitts GR; Youngren OM; Silsby JL; Rozenboim I; Chaiseha Y; Phillips RE; Foster DN; el Halawani ME
    Biol Reprod; 1994 Jun; 50(6):1350-6. PubMed ID: 8080923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide.
    Bardrum B; Ottesen B; Fahrenkrug J; Fuchs AR
    Endocrinology; 1988 Nov; 123(5):2249-54. PubMed ID: 3168920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat.
    Yamaguchi Y; Kobayashi H
    Neuropeptides; 1994 Mar; 26(3):153-8. PubMed ID: 8208360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral actions of vasoactive intestinal peptide (VIP).
    Cottrell GA; Veldhuis HD; Rostene WH; de Kloet ER
    Neuropeptides; 1984 Jun; 4(4):331-41. PubMed ID: 6089028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats.
    Gardiner SM; Rakhit T; Kemp PA; March JE; Bennett T
    Br J Pharmacol; 1994 Feb; 111(2):589-97. PubMed ID: 7911721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateralized learning and memory effects of vasoactive intestinal peptide infused into the rat hippocampal CA1 area.
    Ivanova M; Ternianov A; Tashev R; Belcheva S; Belcheva I
    Regul Pept; 2009 Aug; 156(1-3):42-6. PubMed ID: 19465061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of [4Cl-D-Phe6,Leu17]VIP on the inhibition of pulsatile LH release by VIP and related peptides in the ovariectomized rat.
    Weick RF; Stobie KM; Noh KA
    Neuroendocrinology; 1992 Nov; 56(5):646-52. PubMed ID: 1488097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that noradrenergic activity does not mediate the inhibition of luteinizing hormone secretion caused by vasoactive intestinal peptide.
    Alexander MJ; Clifton DK; Matsumoto AM; Steiner RA
    Brain Res; 1988 Apr; 445(2):247-53. PubMed ID: 3130956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide (VIP): an amnestic neuropeptide.
    Flood JF; Garland JS; Morley JE
    Peptides; 1990; 11(5):933-8. PubMed ID: 2178250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of prolactin secretion by dopamine and vasoactive intestinal peptide at the level of the pituitary in the turkey.
    Youngren OM; Chaiseha Y; El Halawani ME
    Neuroendocrinology; 1998 Nov; 68(5):319-25. PubMed ID: 9822799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide inhibits luteinizing hormone secretion: the inhibition is not mediated by dopamine.
    Stobie KM; Weick RF
    Neuroendocrinology; 1989 Jun; 49(6):597-603. PubMed ID: 2671777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide (VIP) is a modulator of joint pain in a rat model of osteoarthritis.
    McDougall JJ; Watkins L; Li Z
    Pain; 2006 Jul; 123(1-2):98-105. PubMed ID: 16564620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vasoactive intestinal peptide on dopaminergic system in the rat brain.
    Itoh S; Katsuura G; Takashima A
    Peptides; 1988; 9(2):315-7. PubMed ID: 3375138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.